Global Genetic Engineering Industry

NEW YORK, March 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Genetic Engineering Industry

http://www.reportlinker.com/p0152432/Global-Genetic-Engineering-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genetical

The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers an aerial view of the industry, highlights latest developments, and discusses demand drivers, issues and concerns, and regulatory environment. Discussion on the industry's most noteworthy regional market, the US, is amply detailed with unbiased research commentary to provide the reader a rudimentary understanding of the prevailing market climate. Market discussions in the report are punctuated with fact-rich market data tables. Regional markets elaborated upon include United States, Canada, India, China, and South Africa among others. Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 153 companies active in the market.

1. INDUSTRY OVERVIEW 1Genetic Engineering: A Prelude 1Genetic Engineering: Not the Same As Biotechnology 1The Evolution and Progress of GM Crops 2M Crops Gain Global Acceptance 2GM Cultivation Gains Prominence in Developing Nations 2Rising Prices, Food Shortage Make Biotech Grains Attractive 2Socio-Economic Impacts of Biotech Crops 3Impact of GM Crops on Biodiversity 3Challenges to GM Crops Adoption 3Biotech Regulatory Measures Hinder Crop Domestication 4Genetic Modification of Forest Trees and Associated Issues 4Biosafety: a Key Criterion Associated 4Governments Not to Give Up on GM Hope 4US - The Largest Producer of GM Crops 5Leading Countries by Biotech Crop Area (2009) 5Table 1: Current and Future Analysis of the Global BiotechCrops Market By Geographic Region for the US, Canada,Asia-Pacific, Latin America and Rest of World IndependentlyAnalyzed with Annual Sales Figures in US$ Million for 2010through 2015 6Major Market Participants 7

2. MARKET DYNAMICS 8

Global Food Demand to Drive Need for GM Crops 8

Developing Countries: Major Share Holders for Biotech Crop

Production 8

Status of Biotech Rice in the World 8

Genetic Engineering - A Solution for Food Crisis! 9

Harmful or Healthy: Breaking The Myth About GM Crops 9

Non-food Sectors to Benefit from GE Technology 9

Genetic Engineering and Enzymes 9

GE to Help Starch and Sugar Processing Enzyme Market 10

GE to Drive Demand for Bakery Enzymes 10

Genetic Engineering Revolutionizes Vaccines 10

Plant Expression Systems to Replace Traditional Expression

Systems 11

Approved Gene Therapies Fail to Gather Momentum 12

P53 Gene Therapy - A Novel Approach in Cancer Treatment 12

3. ISSUES AND CONCERNS 13The GM Food Issue Continues 13Nations at Crossroads to Accept or Object GE Crops 13Nations Set Global Agenda to Settle GM Crop Controversies 14Challenges Confronting the Biotechs 14Efficacy - The Key Challenge for Gene Therapy 14Key Factors Affecting the Indian Biotechnology Industry 15

4. REGIONAL TRENDS 16

Genetic Engineering: A Fast Catching Trend in Developing

Countries 16

Future of GE Technologies 17

US: Owns a Lion's Share of the World Biotech Produce 17

Table 2: US Biotech Crop Produce By Year in Millions of

Hectares 17

GM Crops Fail to Live up to Expectations in the US 18

US Soybean and Corn Crop to Witness Robust Growth 18

FDA Compliance to Spur Growth in the US Biotech Industry 18

Canada Reaches Million Acres Mark 18

Table 3: Canadian Biotech Crop Produce by Leading Crops

(2011) 19

Table 4: Biotech Maize in Canada: Percentage Share Breakdownby Varieties with Single Stacked gene, Two Stacked genes, andTriple Stacked genes (2011) 19Small and Medium Sized Biotech Enterprises to Grow in Europe 19Germany and UK- The Hub of European Gene Therapy Market 20Spain Garners Leading Spot in Europe's GM Maize Market 20Table 5: Biotech Maize Hectarage in Europe (2011) 20GMO Crops' Future Hinges on Co-Existence Measures in EU 21European Commission Downplays Impact of GM Crops 21Biotech Crops Remain in a Political Standstill in Europe 21European Nations Ban GM Potato and Maize 21UK Government's GM Crops Proposal Faces Rebuff 22Spanish Transgenic Corn Plantation Increases 22Ireland: A GM-free Zone 22Gene Therapy Pipeline Strengthens in Asia 23GM Foods Trends in Asia 23Bt Cotton Fails in Asia 24Chinese Biopharmaceutical Market to Continue its Growth Spurt 24Government to Support Biopharmaceutical Innovation 24Biotech Crop Research Gains Momentum in India 25The Great Indian Bt Brinjal Controversy 25India - The Leading Cultivator of Bt Cotton 25India Ousts China in Bt Cotton Cultivation 25Indian Agri-Bio Industry on a Roll 26India: Ban on Genetically Engineered Crops? 26Legalization of Genetic Engineering in Indonesia 26GM Crops to Earn Good Returns for Australia 26Biotechnology - A Boon for Agriculture in Malaysia 27Poor Biotech Crops Adoption in Africa 27Biotech Crops Cultivation Zooms in South Africa 27Table 6: Percentage Share Breakdown of Biotech Maize by Type(2011) in South Africa 28

Table 7: Percentage Share Breakdown of Biotech Cotton by Type

(2011) in South Africa 28

Uruguayan Community Resist GM Plants 28

GM Crop Adoption Rate Grows Exponentially in Brazil 28

5. GENETIC ENGINEERING: AN OVERVIEW 29The Concept 29Molecular Basics - The Gene 30Genome - The Information Pool 30Evolution of Genetic Engineering 30Historical Developments in Genetic Engineering: 31The Human Genome Project 31Significant Events in the Past 32Gene Therapy 32Types of Gene Therapy 33Monogenic Gene Therapy 33Suicide Gene Therapy 33Antisense Gene Therapy 33Human Genetic Engineering 33Genetic Engineering in Animals 33Role of Biotechnology in Agriculture 34Insect Resistant Crops Vs. Herbicide Tolerant Crops 34Some Interesting GM Crop Facts 35Myths and Fads Associated to Genetically Engineered Crops 35Improvement of Genetic Characters in Wheat 36Agrobacterium tumifaciens Mediated Transformation 36The Biolistic Transformation Method 37Genetically Modified Foods 37GM Food Faces Worldwide Criticism During Initial Years 37Benefits of Genetically Modified Foods 38Pest Resistance 39Cold Tolerance 39Herbicide Tolerance 39Drought and Salinity Tolerance 39Disease Resistance 39Phytoremediation 40Nutrition 40Pharmaceuticals 40Negative Impacts of GM Foods 40Possibility of Crosspollination 40Decreased Pesticides Effectiveness 40Unintentional Destruction of Other Species 41Health Concerns Related to GM Foods 41Cost Concerns Related to GM Foods 41Genetic Engineering and Food Processing 42Genetic Engineering and Regulatory Environment 42Patents - An Overview 43

6. GENE THERAPY - A REVIEW 44

Factors Influencing Gene Therapy's Future Development 44

Human Genome Analysis 44

Gene Therapy - The Next Generation Cardiovascular Therapy 44

Public Support for Gene Therapy 44

RNAi Bode Bright Prospects 44

Factors Hampering Gene Therapy Future Development 45

Stringent US and European Regulatory Laws Prolongs Gene

Therapy Development 45

Identifying Genetic Fault 45

Immune Response 45

Delivering Genetic Materials into Patient Cells 45

Multigene Disorders 46

Side Effects 46

Push Towards Germline Gene Transfer 46

Technical Limitations 46

Commercialization: A Road Uphill 47

Time Line in Gene Therapy Drug Development 47

Table 8: Gene Therapy Clinical Trials (2011): Percentage

Breakdown by Geographic Region for the US, Europe, Canada,

Japan and Rest of World 47

Table 9: Gene Therapy Clinical Development (2011):Percentage Share Breakdown by Stage 48Select Gene Therapy Products in Phase III Development (2010) 48Select Gene Therapy Products in Phase II Development (2010) 49Select Gene Therapy Products in Phase I and Pre-ClinicalDevelopment (2010) 49Target Diseases and Players Involved 50Key Players by Application Area 50Table 10: Clinical Development of Gene Therapy by TargetedIndication (2011): Percentage Breakdown of Number of Trialsfor Cancer Diseases, Cardiovascular Diseases, InfectiousDiseases, Monogenic Diseases, Neurological Diseases andOthers 50

Table 11: Gene Therapy Clinical Trials Worldwide (2011):

Percentage Breakdown by Gene Type Transferred - Antigen,

Cytokine, Tumor Suppressor, Growth Factor, Deficiency,

Suicide, and Others 51

Table 12: Gene Therapy Clinical Development by Vectors Used(2011): Percentage Breakdown of Number of Trials forAdenovirus, Retrovirus, Plasmid DNA, Vaccinia Virus,Lipofection and Others 51Gene Therapy Industry in Europe and the US - A Comparison 51

7. GENE AMPLIFICATION TECHNOLOGY 53

Definition of Gene Amplification 53

Target vs. Signal Amplification 53

Available Types of Gene Amplification Technologies 53

Polymerase Chain Reaction 53

The PCR comprises four major components: 53

Reagents and Equipment Required for PCR 54

Reaction Steps 54

Denaturation 54

Annealing 54

Extension 54

Detection of Amplified Product/DNA 55

(Q&Q) PCR 55

Reverse Transcriptase PCR (RT-PCR) 56

Alternative Technologies to PCR 56

OmniPlex 56

Genome-wide disease association studies 56

Pharmacogenomics studies 56

Molecular diagnostics and forensics 56

Additional OmniPlex Applications in Development 56

Strand Displacement Amplification 57

Ligase Chain Reaction 57

LCR Involves a Cyclic two-Step Reaction 57

Gene Amplification Technology (GAT) 57

Hybrid Capture 57

Isothermal DNA Amplification Techniques 58

Rolling Circle Amplification in Diagnostics 58

Ican Isothermal Gene Amplification Technology 58

BioHelix HDA Technology 58

Other Amplification Technologies 58

Signal Amplification Technology 58

Transcription Mediated Amplification 59

DNA Cleavage-based Signal Amplification 59

Ramification Amplification Method 59

End Use Market Analysis 59

Medical and Diagnostics 59

Role of Amplification Technology in the Diagnoses of

Infectious Diseases 60

Diagnosis of Infectious Diseases by PCR 60

Detection of Antimicrobial Resistance 61

PCR Based Nucleic Acid Amplification for Detection of

Antimicrobial Agents 61

Nucleic Acid Amplification Testing (NAT) 61

Nucleic Acid Amplification Methods 62

DNA Amplification Technology in the Diagnosis of Infectious

Diseases 62

Advantages 62

Limitations 62

Forensic and Paternity Testing 62

Food Safety 63

Table 13: Current and Future Analysis for Global Gene

Amplification Technology Market by Segment Independently

Analyzed with Annual Sales Figures in US$ Million for 2010

Through 2015 64

Table 14: Global Gene Amplification Market (2012): PercentageBreakdown of Value Sales by Geographic Region- the US,Canada, Japan, Europe and Rest of World 64

8. RESEARCH AND DEVELOPMENT 65

9. MERGERS & ACQUISITIONS 70

10. RECENT INDUSTRY ACTIVITY 76

11. PRODUCT/SERVICE LAUNCHES 91GLOBAL DIRECTORY

To order this report:Genetically Modified Organism, GMO Industry: Global Genetic Engineering Industry

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker